Three large NGOs expressed concern that Big Pharma is attempting to influence EU drug reforms by pushing for new incentives for innovation, while rising medicine costs are creating health inequalities. They urge governments to ensure affordable access to medicines. Discussions on the reform have progressed slowly, with pharmaceutical companies advocating for stronger intellectual property protections, while civil society groups call for reduced regulatory data protection to allow earlier market entry for generics. The situation is complicated by fears of a pharmaceutical trade war and the impact of US drug pricing policies. Teljes cikk (Euronews.com)